1932

Abstract

There is a great deal of interest in personalized, individualized, or precision interventions for disease and health-risk mitigation. This is as true of nutrition-based intervention and prevention strategies as it is for pharmacotherapies and pharmaceutical-oriented prevention strategies. Essentially, technological breakthroughs have enabled researchers to probe an individual's unique genetic, biochemical, physiological, behavioral, and exposure profile, allowing them to identify very specific and often nuanced factors that an individual might possess, which may make it more or less likely that he or she responds favorably to a particular intervention (e.g., nutrient supplementation) or disease prevention strategy (e.g., specific diet). However, as compelling and intuitive as personalized nutrition might be in the current era in which data-intensive biomedical characterization of individuals is possible, appropriately and objectively vetting personalized nutrition strategies is not trivial and requires novel study designs and data analytical methods. These designs and methods must consider a very integrated use of the multiple contemporary biomedical assays and technologies that motivate them, which adds to their complexity. Single-subject or N-of-1 trials can be used to assess the utility of personalized interventions and, in addition, can be crafted in such a way as to accommodate the necessarily integrated use of many emerging biomedical technologies and assays. In this review, we consider the motivation, design, and implementation of N-of-1 trials in translational nutrition research that are meant to assess the utility of personalized nutritional strategies. We provide a number of example studies, discuss appropriate analytical methods given the complex data they generate and require, and consider how such studies could leverage integration of various biomarker assays and clinical end points. Importantly, we also consider the development of strategies and algorithms for matching nutritional needs to individual biomedical profiles and the issues surrounding them. Finally, we discuss the limitations of personalized nutrition studies, possible extensions of N-of-1 nutritional intervention studies, and areas of future research.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-nutr-071816-064717
2017-08-21
2024-06-12
Loading full text...

Full text loading...

/deliver/fulltext/nutr/37/1/annurev-nutr-071816-064717.html?itemId=/content/journals/10.1146/annurev-nutr-071816-064717&mimeType=html&fmt=ahah

Literature Cited

  1. Afaghi A, O'Connor H, Chow CM. 1.  2007. High-glycemic-index carbohydrate meals shorten sleep onset. Am. J. Clin. Nutr. 85:426–30 [Google Scholar]
  2. Allison DB, Bassaganya-Riera J, Burlingame B, Brown AW, le Coutre J. 2.  et al. 2015. Goals in nutrition science 2015–2020. Front. Nutr. 2:26 [Google Scholar]
  3. Anderson L, Razavi M, Skates S, Anderson NG, Pearson TW. 3.  2016. Squeezing more value from the analytes we have: personal baselines for multiple analytes in serial DBS. Bioanalysis 8:1539–42 [Google Scholar]
  4. Anoushiravani AA, Patton J, Sayeed Z, El-Othmani MM, Saleh KJ. 4.  2016. Big data, big research: implementing population health-based research models and integrating care to reduce cost and improve outcomes. Orthop. Clin. North Am. 47:717–24 [Google Scholar]
  5. Aslibekyan S, Claas SA, Arnett DK. 5.  2013. To replicate or not to replicate: the case of pharmacogenetic studies: establishing validity of pharmacogenomic findings: from replication to triangulation. Circ. Cardiovasc. Genet. 6:409–12; discuss. 12 [Google Scholar]
  6. Bagne CA, Lewis RF. 6.  1992. Evaluating the effects of drugs on behavior and quality of life: an alternative strategy for clinical trials. J. Consult. Clin. Psychol. 60:225–39 [Google Scholar]
  7. Beutler E. 7.  1994. G6PD deficiency. Blood 84:3613–36 [Google Scholar]
  8. Blau N, van Spronsen FJ, Levy HL. 8.  2010. Phenylketonuria. Lancet 376:1417–27 [Google Scholar]
  9. Bloomgarden ZT. 9.  2006. Measures of insulin sensitivity. Clin. Lab. Med. 26:611–33vi [Google Scholar]
  10. Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S. 10.  et al. 2015. Dietary modulation of the gut microbiota—a randomised controlled trial in obese postmenopausal women. Br. J. Nutr. 114:406–17 [Google Scholar]
  11. Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA. 11.  2003. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J. Clin. Endocrinol. Metab. 88:1617–23 [Google Scholar]
  12. Cardon LR, Bell JI. 12.  2001. Association study designs for complex diseases. Nat. Rev. Genet. 2:91–99 [Google Scholar]
  13. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P. 13.  et al. 2011. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364:2507–16 [Google Scholar]
  14. Chen LY, Tee BC, Chortos AL, Schwartz G, Tse V. 14.  et al. 2014. Continuous wireless pressure monitoring and mapping with ultra-small passive sensors for health monitoring and critical care. Nat. Commun. 5:5028 [Google Scholar]
  15. Chen X, Chen P. 15.  2014. A comparison of four methods for the analysis of N-of-1 trials. PLOS ONE 9:e87752 [Google Scholar]
  16. Chen Y, Elenee Argentinis JD, Weber G. 16.  2016. IBM Watson: how cognitive computing can be applied to big data challenges in life sciences research. Clin. Ther. 38:688–701 [Google Scholar]
  17. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N. 17.  et al. 2013. Dietary intervention impact on gut microbial gene richness. Nature 500:585–88 [Google Scholar]
  18. Coveney PV, Dougherty ER, Highfield RR. 18.  2016. Big data need big theory too. Philos. Trans. R. Soc. Ser. A 374:208020160153 [Google Scholar]
  19. Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E. 19.  et al. 2016. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:426–36 [Google Scholar]
  20. David LA, Materna AC, Friedman J, Campos-Baptista MI, Blackburn MC. 20.  et al. 2014. Host lifestyle affects human microbiota on daily timescales. Genome Biol 15:R89; Erratum. Genome Biol. 2016. 17:1117 [Google Scholar]
  21. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE. 21.  et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559–63 [Google Scholar]
  22. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG. 22.  et al. 2013. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62:1112–21 [Google Scholar]
  23. Domenech M, Roman P, Lapetra J, Garcia de la Corte FJ, Sala-Vila A. 23.  et al. 2014. Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial. Hypertension 64:69–76 [Google Scholar]
  24. Drescher CW, Shah C, Thorpe J, O'Briant K, Anderson GL. 24.  et al. 2013. Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. J. Clin. Oncol. 31:387–92 [Google Scholar]
  25. Duan N, Kravitz RL, Schmid CH. 25.  2013. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J. Clin. Epidemiol. 66:S21–28 [Google Scholar]
  26. Dugard P, File P, Todman J. 26.  2011. Single-Case and Small-n Experimental Designs: A Practical Guide to Randomization Tests New York: Routledge, 2nd ed.. [Google Scholar]
  27. Elias MC, Parise ER, de Carvalho L, Szejnfeld D, Netto JP. 27.  2010. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition 26:1094–99 [Google Scholar]
  28. Evenson KR, Goto MM, Furberg RD. 28.  2015. Systematic review of the validity and reliability of consumer-wearable activity trackers. Int. J. Behav. Nutr. Phys. Act. 12:159 [Google Scholar]
  29. Fawcett T. 29.  2015. Mining the quantified self: personal knowledge discovery as a challenge for data science. Big Data 3:249–66 [Google Scholar]
  30. Fenech M. 30.  2001. The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat. Res. 475:57–67 [Google Scholar]
  31. Fenech M, Baghurst P, Luderer W, Turner J, Record S. 31.  et al. 2005. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability—results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26:991–99 [Google Scholar]
  32. Fisher-Wellman KH, Ryan TE, Smith CD, Gilliam LA, Lin CT. 32.  et al. 2016. A direct comparison of metabolic responses to high-fat diet in C57BL/6J and C57BL/6NJ mice. Diabetes 65:3249–61 [Google Scholar]
  33. Frankwich KA, Egnatios J, Kenyon ML, Rutledge TR, Liao PS. 33.  et al. 2015. Differences in weight loss between persons on standard balanced vs nutrigenetic diets in a randomized controlled trial. Clin. Gastroenterol. Hepatol. 13:162532.e1 quiz e145–46 [Google Scholar]
  34. Fumagalli M, Moltke I, Grarup N, Racimo F, Bjerregaard P. 34.  et al. 2015. Greenlandic Inuit show genetic signatures of diet and climate adaptation. Science 349:1343–47 [Google Scholar]
  35. Garrod AE. 35.  2002 (1902). The incidence of alkaptonuria: a study in chemical individuality. Lancet161–20 Yale J. Biol. Med 75:221–31 [Google Scholar]
  36. Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP. 36.  et al. 2012. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 308:1871–80 [Google Scholar]
  37. Gill S, Panda S. 37.  2015. A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits. Cell Metab 22:789–98 [Google Scholar]
  38. Gimbert C, Lapointe FJ. 38.  2015. Self-tracking the microbiome: Where do we go from here?. Microbiome 3:70 [Google Scholar]
  39. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C. 39.  et al. 1998. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann. Intern. Med. 129:517–24 [Google Scholar]
  40. Goni L, Cuervo M, Milagro FI, Martinez JA. 40.  2014. Gene-gene interplay and gene-diet interactions involving the MTNR1B rs10830963 variant with body weight loss. J. Nutrigenet. Nutrigenomics 7:232–42 [Google Scholar]
  41. Gorman U, Mathers JC, Grimaldi KA, Ahlgren J, Nordstrom K. 41.  2013. Do we know enough? a scientific and ethical analysis of the basis for genetic-based personalized nutrition. Genes Nutr 8:373–81 [Google Scholar]
  42. Green AL, Shad A, Watson R, Nandi D, Yianni J, Aziz TZ. 42.  2004. N-of-1 trials for assessing the efficacy of deep brain stimulation in neuropathic pain. Neuromodulation 7:76–81 [Google Scholar]
  43. Guasch-Ferré M, Bullo M, Martinez-Gonzalez MA, Ros E, Corella D. 43.  et al. 2013. Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial. BMC Med 11:164 [Google Scholar]
  44. Guessous I, Gwinn M, Khoury MJ. 44.  2009. Genome-wide association studies in pharmacogenomics: untapped potential for translation. Genome Med 1:46 [Google Scholar]
  45. Harper AR, Topol EJ. 45.  2012. Pharmacogenomics in clinical practice and drug development. Nat. Biotechnol. 30:1117–24 [Google Scholar]
  46. Hingle M, Patrick H. 46.  2016. There are thousands of apps for that: navigating mobile technology for nutrition education and behavior. J. Nutr. Educ. Behav. 48:213–18.e1 [Google Scholar]
  47. Hogben L, Sim M. 47.  1953. The self-controlled and self-recorded clinical trial for low-grade morbidity. Br. J. Prev. Soc. Med. 7:163–79 [Google Scholar]
  48. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML. 48.  et al. 2006. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295:655–66 [Google Scholar]
  49. Ioannidis JP. 49.  2013. To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication?. Circ. Cardiovasc. Genet 6:413–8; discuss 18 [Google Scholar]
  50. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM. 50.  et al. 2010. Association of Western and traditional diets with depression and anxiety in women. Am. J. Psychiatry 167:305–11 [Google Scholar]
  51. Jenkins MJ, Farid SS. 51.  2015. Human pluripotent stem cell–derived products: advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol. J. 10:83–95 [Google Scholar]
  52. Jennings A, Welch AA, Spector T, Macgregor A, Cassidy A. 52.  2014. Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J. Nutr. 144:202–8 [Google Scholar]
  53. Jones B, Kenward MG. 53.  2014. Design and Analysis of Cross-Over Trials Boca Raton, FL: Chapman & Hall/CRC, 3rd ed.. [Google Scholar]
  54. Kaput J. 54.  2016. Systems-level nutrition approaches to define phenotypes resulting from complex gene-environment interactions. Nestle Nutr. Inst. Workshop Ser. 84:1–13 [Google Scholar]
  55. Kaput J, Morine M. 55.  2012. Discovery-based nutritional systems biology: developing N-of-1 nutrigenomic research. Int. J. Vitam. Nutr. Res. 82:333–41 [Google Scholar]
  56. Killer SC, Svendsen IS, Jeukendrup AE, Gleeson M. 56.  2015. Evidence of disturbed sleep and mood state in well-trained athletes during short-term intensified training with and without a high carbohydrate nutritional intervention. J. Sports Sci. 35:1402–10 [Google Scholar]
  57. Kim J. 57.  2014. Analysis of health consumers' behavior using self-tracker for activity, sleep, and diet. Telemed. J. e-Health 20:552–58 [Google Scholar]
  58. Konstantinidou V, Covas MI, Munoz-Aguayo D, Khymenets O, de la Torre R. 58.  et al. 2010. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB J 24:2546–57 [Google Scholar]
  59. Kraft P, Zeggini E, Ioannidis JP. 59.  2009. Replication in genome-wide association studies. Stat. Sci. 24:561–73 [Google Scholar]
  60. Kussmann M, Affolter M. 60.  2009. Proteomics at the center of nutrigenomics: comprehensive molecular understanding of dietary health effects. Nutrition 25:1085–93 [Google Scholar]
  61. Kussmann M, Van Bladeren PJ. 61.  2011. The extended nutrigenomics—understanding the interplay between the genomes of food, gut microbes, and human host. Front. Genet. 2:21 [Google Scholar]
  62. Kussmann MF, Fay LB. 62.  2008. Nutrigenomics and personalized nutrition: science and concept. Pers. Med. 5:447–55 [Google Scholar]
  63. Lamb BW, Brown KF, Nagpal K, Vincent C, Green JS, Sevdalis N. 63.  2011. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann. Surg. Oncol. 18:2116–25 [Google Scholar]
  64. Laursen L. 64.  2010. Interdisciplinary research: big science at the table. Nature 468:S2–4 [Google Scholar]
  65. Lemaire JB, Wallace JE, Dinsmore K, Lewin AM, Ghali WA, Roberts D. 65.  2010. Physician nutrition and cognition during work hours: effect of a nutrition based intervention. BMC Health Serv. Res. 10:241 [Google Scholar]
  66. Leonardson AS, Zhu J, Chen Y, Wang K, Lamb JR. 66.  et al. 2010. The effect of food intake on gene expression in human peripheral blood. Hum. Mol. Genet. 19:159–69 [Google Scholar]
  67. Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. 67.  2011. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?. Pers. Med. 8:161–73 [Google Scholar]
  68. Lin SX, Morrison L, Smith PW, Hargood C, Weal M, Yardley L. 68.  2016. Properties of bootstrap tests for N-of-1 studies. Br. J. Math. Stat. Psychol. 69:276–90 [Google Scholar]
  69. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM. 69.  et al. 2009. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39–51 [Google Scholar]
  70. Wing RR, Bolin P, Brancati FL, Bray GA. 70. Look AHEAD Res. Group et al. 2013. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N. Engl. J. Med. 369:145–54 [Google Scholar]
  71. Lopes Gomes D, Moehlecke M, Lopes da Silva FB, Dutra ES, D'Agord Schaan B, Baiocchi de Carvalho KM. 71.  2016. Whey protein supplementation enhances body fat and weight loss in women long after bariatric surgery: a randomized controlled trial. Obes. Surg. 27:424–31 [Google Scholar]
  72. Macey PM, Schluter PJ, Macey KE, Harper RM. 72.  2016. Detecting variable responses in time-series using repeated measures ANOVA: application to physiologic challenges. F1000Res 5:563 [Google Scholar]
  73. Maher M, Pooler AM, Kaput J, Kussmann M. 73.  2016. A systems approach to personalised nutrition: report on the Keystone Symposium “Human Nutrition, Environment and Health.”. Appl. Transl. Genom. 10:16–18 [Google Scholar]
  74. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. 74.  2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81:230S–42S [Google Scholar]
  75. Martin CK, Bhapkar M, Pittas AG, Pieper CF, Das SK. 75.  et al. 2016. Effect of calorie restriction on mood, quality of life, sleep, and sexual function in healthy nonobese adults: the CALERIE 2 randomized clinical trial. JAMA Intern. Med. 176:743–52 [Google Scholar]
  76. Masters JR, Stacey GN. 76.  2007. Changing medium and passaging cell lines. Nat. Protoc. 2:2276–84 [Google Scholar]
  77. Matsuda M, DeFronzo RA. 77.  1999. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–70 [Google Scholar]
  78. McCann JC, Shigenaga MK, Mietus-Snyder ML, Lal A, Suh JH. 78.  et al. 2015. A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements. FASEB J 29:3287–301 [Google Scholar]
  79. McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A. 79.  et al. 2003. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14:1–12 [Google Scholar]
  80. Menotti A, Kromhout D, Blackburn H, Fidanza F, Buzina R, Nissinen A. 80.  1999. Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. Eur. J. Epidemiol. 15:507–15 [Google Scholar]
  81. Monteiro JP, Kussmann M, Kaput J. 81.  2015. The genomics of micronutrient requirements. Genes Nutr 10:466 [Google Scholar]
  82. Muniyappa R, Lee S, Chen H, Quon MJ. 82.  2008. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metab. 294:E15–26 [Google Scholar]
  83. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E. 83. NCI-NHGRI Work. Group Replication Assoc. Stud. et al. 2007. Replicating genotype-phenotype associations. Nature 447:655–60 [Google Scholar]
  84. Norris KM, Okie W, Kim WK, Adhikari R, Yoo S. 84.  et al. 2016. A high-fat diet differentially regulates glutathione phenotypes in the obesity-prone mouse strains DBA/2J, C57BL/6J, and AKR/J. Nutr. Res. 36:1316–24 [Google Scholar]
  85. Nunes-Alves C. 85.  2016. Microbiome: microbiota-based nutrition plans. Nat. Rev. Microbiol. 14:1 [Google Scholar]
  86. Olson CM. 86.  2016. Behavioral nutrition interventions using e- and m-health communication technologies: a narrative review. Annu. Rev. Nutr. 36:647–64 [Google Scholar]
  87. Patrick K, Raab F, Adams MA, Dillon L, Zabinski M. 87.  et al. 2009. A text message–based intervention for weight loss: randomized controlled trial. J. Med. Internet. Res 11:e1 [Google Scholar]
  88. Pirmohamed M. 88.  2001. Pharmacogenetics and pharmacogenomics. Br. J. Clin. Pharmacol. 52:345–47 [Google Scholar]
  89. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH. 89.  et al. 2006. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295:629–42 [Google Scholar]
  90. Pu S, Eck P, Jenkins DJ, Connelly PW, Lamarche B. 90.  et al. 2016. Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition. Br. J. Nutr. 115:1012–23 [Google Scholar]
  91. Punja S, Bukutu C, Shamseer L, Sampson M, Hartling L. 91.  et al. 2016. N-of-1 trials are a tapestry of heterogeneity. J. Clin. Epidemiol. 76:47–56 [Google Scholar]
  92. Punja S, Xu D, Schmid CH, Hartling L, Urichuk L. 92.  et al. 2016. N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis. J. Clin. Epidemiol. 76:65–75 [Google Scholar]
  93. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC. 93.  et al. 2009. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J. Natl. Cancer Inst. 101:507–18 [Google Scholar]
  94. Rahe C, Unrath M, Berger K. 94.  2014. Dietary patterns and the risk of depression in adults: a systematic review of observational studies. Eur. J. Nutr. 53:997–1013 [Google Scholar]
  95. Reed DR. 95.  2008. Animal models of gene-nutrient interactions. Obesity 16:Suppl. 323S–27S [Google Scholar]
  96. Renda G, Zimarino M, Antonucci I, Tatasciore A, Ruggieri B. 96.  et al. 2012. Genetic determinants of blood pressure responses to caffeine drinking. Am. J. Clin. Nutr. 95:241–48 [Google Scholar]
  97. Renfro LA, Sargent DJ. 97.  2016. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples. Ann. Oncol. 28:34–43 [Google Scholar]
  98. Ritchie MD. 98.  2012. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum. Genet. 131:1615–26 [Google Scholar]
  99. Rochon J. 99.  1990. A statistical model for the “N-of-1” study. J. Clin. Epidemiol. 43:499–508 [Google Scholar]
  100. Roses AD. 100.  2000. Pharmacogenetics and the practice of medicine. Nature 405:857–65 [Google Scholar]
  101. Schork NJ. 101.  2015. Personalized medicine: time for one-person trials. Nature 520:609–11 [Google Scholar]
  102. Scriver CR. 102.  2007. The PAH gene, phenylketonuria, and a paradigm shift. Hum. Mutat. 28:831–45 [Google Scholar]
  103. Scuffham PA, Nikles J, Mitchell GK, Yelland MJ, Vine N. 103.  et al. 2010. Using N-of-1 trials to improve patient management and save costs. J. Gen. Intern. Med. 25:906–13 [Google Scholar]
  104. Senn S. 104.  2002. Cross-Over Trials in Clinical Research New York: Wiley, 2nd.. [Google Scholar]
  105. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C. 105.  et al. 2008. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300:2123–33 [Google Scholar]
  106. Seto T, Kato T, Nishio M, Goto K, Atagi S. 106.  et al. 2014. Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study. Lancet Oncol 15:1236–44 [Google Scholar]
  107. Shab-Bidar S, Neyestani TR, Djazayery A. 107.  2015. Vitamin D receptor Cdx-2-dependent response of central obesity to vitamin D intake in the subjects with type 2 diabetes: a randomised clinical trial. Br. J. Nutr. 114:1375–84 [Google Scholar]
  108. Shull PB, Jirattigalachote W, Hunt MA, Cutkosky MR, Delp SL. 108.  2014. Quantified self and human movement: a review on the clinical impact of wearable sensing and feedback for gait analysis and intervention. Gait Posture 40:11–19 [Google Scholar]
  109. Simon R. 109.  1977. Adaptive treatment assignment methods and clinical trials. Biometrics 33:743–49 [Google Scholar]
  110. Smits SA, Marcobal A, Higginbottom S, Sonnenburg JL, Kashyap PC. 110.  2016. Individualized responses of gut microbiota to dietary intervention modeled in humanized mice. mSystems 1:5e00098–16 [Google Scholar]
  111. Stumbo PJ, Weiss R, Newman JW, Pennington JA, Tucker KL. 111.  et al. 2010. Web-enabled and improved software tools and data are needed to measure nutrient intakes and physical activity for personalized health research. J. Nutr. 140:2104–15 [Google Scholar]
  112. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H. 112.  et al. 2000. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301 [Google Scholar]
  113. Tang SM, MacNeill IB. 113.  1993. The effect of serial correlation on tests for parameter change at unknown time. Ann. Stat. 21:552–75 [Google Scholar]
  114. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. 114.  2002. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am. J. Psychiatry 159:2099–101 [Google Scholar]
  115. Tiscornia G, Vivas EL, Izpisua Belmonte JC. 115.  2011. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat. Med. 17:1570–76 [Google Scholar]
  116. Uryniak TC, Chan ISF, Fedorov VV, Jiang Q, Oppenheimer S. 116.  et al. 2011. Responder analyses—a PhRMA position paper. Stat. Biopharm. Res. 3:476–87 [Google Scholar]
  117. van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA. 117.  et al. 2012. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur. J. Clin. Nutr. 66:399–404 [Google Scholar]
  118. van Ommen B, El-Sohemy A, Hesketh J, Kaput J, Fenech M. 118.  et al. 2010. The Micronutrient Genomics Project: a community-driven knowledge base for micronutrient research. Genes Nutr 5:285–96 [Google Scholar]
  119. Vesnic-Alujevic L, Breitegger M, Guimarães Pereira Ã. 119.  2016. ‘Do-it-yourself’ healthcare? Quality of health and healthcare through wearable sensors. Sci. Eng. Ethics. In press [Google Scholar]
  120. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G. 120.  et al. 2011. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5:220–30 [Google Scholar]
  121. Williamson G, Manach C. 121.  2005. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81:243S–55S [Google Scholar]
  122. Wojczynski MK, Parnell LD, Pollin TI, Lai CQ, Feitosa MF. 122.  et al. 2015. Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). Metabolism 64:1359–71 [Google Scholar]
  123. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D. 123.  et al. 2015. Personalized nutrition by prediction of glycemic responses. Cell 163:1079–94 [Google Scholar]
  124. Zheng YL, Ding XR, Poon CC, Lo BP, Zhang H. 124.  et al. 2014. Unobtrusive sensing and wearable devices for health informatics. IEEE Trans. Biomed. Eng. 61:1538–54 [Google Scholar]
/content/journals/10.1146/annurev-nutr-071816-064717
Loading
/content/journals/10.1146/annurev-nutr-071816-064717
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error